Drug recall · September 17, 2025
Ciprofloxacin 0.3% and Dexamethasone 0.1% Otic Suspension recall
Why: Temperature Abuse
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Ciprofloxacin 0.3% and Dexamethasone 0.1% Otic Suspension Rx Only, For Use in Ears Only, Manufactured By: Novartis Manufacturing NV, Belgium, Distributed by: Sandoz, Inc., Princeton, NJ, NDC# 0781-6186-67, Carton NDC# 0781-6186-67
- Lots / codes
Lot # VNF35A, Exp.08/31/2026
- Quantity
- 1,680 bottles
- Company
- Sandoz Inc, Princeton, NJ
- Distribution
- Product was distributed to one consignee in CA.
- Initiated
- August 13, 2025 · Voluntary: Firm initiated
- Classified
- September 10, 2025
- Reported
- September 17, 2025
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Ciprofloxacin / dexamethasone
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.